Css LLC Albireo Pharma, Inc. Call Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $869,856 - $1.41 Million	53,300 New	53,300 $1.03 Million
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $11,970 - $16,870	-500 Reduced 7.69%	6,000 $178,000
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $57,800 - $73,740	-2,000 Reduced 23.53%	6,500 $229,000
Q1 2021 May 17, 2021	BUY	$32.03 - $42.85 $208,195 - $278,525	6,500 Added 325.0%	8,500 $299,000
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $757,440 - $1.01 Million	-24,000 Reduced 92.31%	2,000 $75,000

Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $602,940 - $1.08 Million	26,000 New	26,000 $867,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.